SCHEMBL688296

SCHEMBL688296

CSc1ccccc1Cn1ccc(O)c(NC(=O)N[C@@H](CC(=O)O)c2ccc(C)cc2)c1=O

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CTSA P10619 8/20 0.37
PTGER3 P43115 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
CYP26A1 O43174 2/20 0.35
ITGB1 P05556 2/20 0.33
ITGA4 P13612 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KEAP1 Q14145 2/20 0.33
NFE2L2 Q16236 2/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687280 0.89 POLB (0.43) CTSAPTGER3MEN1KMT2APOLB
SCHEMBL688040 0.88 PTGER3 (0.49) CTSAPTGER3MEN1KMT2APOLB
SCHEMBL688155 0.88 PTGER3 (0.49) CTSAPTGER3MEN1KMT2APOLB
SCHEMBL687761 0.88 CTSA (0.46) CTSAPTGER3MEN1KMT2AALDH1A1
SCHEMBL688191 0.88 ALDH1A1 (0.40) CTSAPTGER3MEN1KMT2APOLB
SCHEMBL688110 0.86 MEN1 (0.49) CTSAMEN1KMT2APOLBCYP26A1
SCHEMBL687559 0.86 ALDH1A1 (0.49) CTSAPTGER3POLBALDH1A1
SCHEMBL686888 0.85 CTSA (0.37) CTSAPTGER3MEN1KMT2APOLB
SCHEMBL688854 0.85 PPARG (0.39) CTSAPTGER3MEN1KMT2APOLB
SCHEMBL688132 0.85 TP53 (0.44) CTSAPTGER3MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed